Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,948.40
(
0.89%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
-2.31%
)
Bitcoin
78,156.40
(
2.39%
)
News Focus
News Focus
Post# of 48316
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

trading.jeff

Send PM Follow Ignore
Followers 659
Posts 47966
Boards Moderated 1
Alias Born 03/30/2009

trading.jeff

Re: ash111 post# 40109

Friday, 10/13/2017 4:09:21 PM

Friday, October 13, 2017 4:09:21 PM

Post# of 48316
According to the article, Merck announced the collaboration:

Merck & Co. Inc. (NYSE:MRK) just announced another move to expand the drug’s addressable market. Merck is now collaborating with biotech company OncoSec Medical Inc. (NASDAQ:ONCS) on a phase II registration trial on melanoma patients.


$ONCS

Success is never final; failure is never fatal. It's courage that counts.--John Wooden (1910-2010)

Courage is being scared to death, but saddling up anyway.--John Wayne (1907-1979)

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote